Program

769
585
109
107
103
36
26
22
16
11
10
10
9
4
3
1

Journal Year Published

4
55
111
103
188
334
338
388
128
65
52
51
37
20
10
4
5
6
3
3

Author

185
178
145
136
125
123
118
117
108
99
88
81
77
58
54
50
46
46
42
37

Category

377
362
314
112
86
72
21
20
19
19
3
2

Keyword

1262
610
560
411
345
302
210
208
160
146
129
122
112
111
100
97
91
83
82
82

Journal

53
51
46
30
28
28
21
19
18
17
17
16
16
16
16
15
14
14
14
13

NCATS Publications

Disposition of human recombinant lubricin in naive rats and in a rat model of post-traumatic arthritis after intra-articular or intravenous administration.


Vugmeyster Y, Wang Q, Xu X, Harrold J, Daugusta D, Li J, Zollner R, Flannery CR, Rivera-Bermúdez MA


AAPS J , (14), 97-104, 2012.

Article Pubmed

Sample image from publication page

Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats.


Barsony J, Manigrasso MB, Xu Q, Tam H, Verbalis JG


Age (Dordr) , (35), 271-88, 2013.

Article Pubmed

Exploring polypharmacology using a ROCS-based target fishing approach.


AbdulHameed MD, Chaudhury S, Singh N, Sun H, Wallqvist A, Tawa G


J Chem Inf Model , (52), 492-505, 2012.

Article Pubmed

Sample image from publication page

Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.


Yeung J, Apopa PL, Vesci J, Kenyon V, Rai Bantukallu G, Jadhav A, Simeonov A, Holman TR, Maloney DJ, Boutaud O, Holinstat M


Mol. Pharmacol. , (81), 420-30, 2012.

Article Pubmed

Sample image from publication page

Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).


Wu Y, Li J, Wu J, Morgan P, Xu X, Rancati F, Vallese S, Raveglia L, Hotchandani R, Fuller N, Bard J, Cunningham K, Fish S, Krykbaev R, Tam S, Goldman SJ, Williams C, Mansour TS, Saiah E, Sypek J, Li W


Bioorg. Med. Chem. Lett. , (22), 138-43, 2012.

Article Pubmed

Sample image from publication page

Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.


Shim JH, Greenblatt MB, Singh A, Brady N, Hu D, Drapp R, Ogawa W, Kasuga M, Noda T, Yang SH, Lee SK, Rebel VI, Glimcher LH


J. Clin. Invest. , (122), 91-106, 2012.

Article Pubmed

Discovery of pyrrolidine-based β-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency.


Stachel SJ, Steele TG, Petrocchi A, Haugabook S, McGaughey G, Katharine Holloway M, Allison T, Munshi S, Zuck P, Colussi D, Tugasheva K, Wolfe A, Graham SL, Vacca JP


Bioorg. Med. Chem. Lett. , (22), 240-4, 2012.

Article Pubmed